Volume 50, Issue 11 pp. 3535-3540
Research Article

Bone morphogenetic protein and transforming growth factor β inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1β

Martina Kaiser

Martina Kaiser

University of Erlangen–Nuremberg, Erlangen, Germany

Search for more papers by this author
Jochen Haag

Jochen Haag

University of Erlangen–Nuremberg, Erlangen, Germany

Search for more papers by this author
Stephan Söder

Stephan Söder

University of Erlangen–Nuremberg, Erlangen, Germany

Search for more papers by this author
Brigitte Bau

Brigitte Bau

University of Erlangen–Nuremberg, Erlangen, Germany

Search for more papers by this author
Thomas Aigner

Corresponding Author

Thomas Aigner

University of Erlangen–Nuremberg, Erlangen, Germany

Osteoarticular and Arthritis Research, Department of Pathology, University of Erlangen–Nuremberg, Krankenhausstrasse 8-10, 91054 Erlangen, GermanySearch for more papers by this author
First published: 04 November 2004
Citations: 36

Abstract

Objective

Bone morphogenetic protein (BMP) and transforming growth factor β (TGFβ) are potent anabolic factors in adult articular chondrocytes. In this study, we investigated whether intracellular inhibitors of BMP and TGFβ signaling, inhibitory Smad6 (I-Smad6) and I-Smad7, are expressed in articular chondrocytes in normal and osteoarthritic (OA) cartilage, and whether their expression shows a correlation with the anabolic activity of OA chondrocytes in vivo and after interleukin-1β (IL-1β) stimulation in vitro.

Methods

RNA isolated directly from normal and OA human knee cartilage as well as from cultured articular chondrocytes was analyzed by (quantitative) polymerase chain reaction technology. Immunolocalization of the I-Smads was performed on tissue sections and compared with the anabolic cellular activity as documented by in situ hybridization experiments for aggrecan and type II collagen.

Results

Both Smad6 and Smad7 were expressed in all samples of normal and OA cartilage. Immunostaining (including confocal microscopy) confirmed the presence of Smad6 and Smad7 in the majority of normal and degenerated articular chondrocytes; localization was mostly cytoplasmic. No correlation between expression of the main anabolic genes and expression of the I-Smads was found. In cultured articular chondrocytes, stimulation with IL-1β showed up-regulation of Smad7, whereas Smad6 was down-regulated.

Conclusion

Both Smad6 and Smad7 are expressed in adult human articular chondrocytes. The primarily cytoplasmic localization suggests permanent activation of the I-Smads in articular cartilage in vivo. No evidence was found that up-regulation or down-regulation of I-Smads in OA cartilage correlates directly with the anabolic (or catabolic) activity of articular chondrocytes. The regulation in chondrocytes of Smad6 and Smad7 expression by IL-1β suggests a potentially important role of IL-1β signaling in chondrocytes, via indirect influencing of the BMP/TGFβ signaling cascade.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me